Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity

Endocrinology

Volumn 144, Issue 9, 2003, Pages 3821-3827

  Chen, Chun Rong ^a   Chazenbalk, Gregorio D ^a   McLachlan, Sandra M ^a   Rapoport, Basil ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHIMERIC PROTEIN; CYCLIC AMP; LUTEINIZING HORMONE RECEPTOR; THYROTROPIN RECEPTOR; TRYPSIN; HYBRID PROTEIN;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONTROLLED STUDY; GENE CLUSTER; GENE MUTATION; NONHUMAN; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ANIMAL; CELL STRAIN COS1; CHEMISTRY; CHO CELL; GENE EXPRESSION; GENETICS; HAMSTER; METABOLISM; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHO CELLS; COS CELLS; CRICETINAE; GENE EXPRESSION; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, LH; RECEPTORS, THYROTROPIN; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPSIN;

EID: 0042421851     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0430     Document Type: Article

References (29)

1. Van Sande J, Swillens S, Gerard C, Allgeier A, Massart C, Vassart G, Dumont J 1995 In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4, 5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence. Eur J Biochem 229:338-343
2. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G 1995 Genetic basis of endocrine disease: somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585
3. 2+ cascades. Mol Endocrinol 9:725-733
4. Zhang M, Phuong K, Tong T, Fremont V, Chen J, Narayan P, Puett D, Weintraub BD, Szkudlinski MW 2000 The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141:3514-3517
5. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746
6. Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G, Dumont JE 1996 Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 119:161-168
7. Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B 1998 Thyrotropin receptor cleavage at site 1 does not involve a specific amino acid motif but instead depends on the presence of the unique, 50 amino acid insertion. J Biol Chem 273:1959-1963
8. Chazenbalk GD, Tanaka K, Nagayama Y, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B 1997 Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology 138:2893-2899
9. De Bernard S, Misrahi M, Huet J-C, Beau I, Desroches A, Loosfelt H, Pichon C, Pernollet J-C, Milgrom E 1999 Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J Biol Chem 274:101-107
10. Chen C-R, Chazenbalk GD, McLachlan SM, Rapoport B 2003 Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-ind ependent activity. Endocrinology 144:1324-1330
11. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190
12. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G, Gudermann T 1998 A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J 12:1461-1471
13. Arseven OK, Wilkes WP, Jameson JL, Kopp P 2000 Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11. Thyroid 10:3-10
14. Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, Rapoport B 1991 Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for TSH receptor function. Proc Natl Acad Sci USA 88:902-905
15. Kakinuma A, Chazenbalk G, Filetti S, McLachlan SM, Rapoport B 1996 Both the 5′ and 3′ non-coding regions of the thyrotropin receptor messenger RNA influence the level of receptor protein expression in transfected mammalian cells. Endocrinology 137:2664-2669
16. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
17. Russo D, Nagayama Y, Chazenbalk GD, Wadsworth HL, Rapoport B 1992 Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor. Endocrinology 130:2135-2138
18. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin receptor: Interaction with thyrotropin and autoantibodies. Endocr Rev 19:673-716
19. Chazenbalk GD, McLachlan SM, Chen C-R, Rapoport B 2001 Insight into thyrotropin receptor cleavage by engineering the single polypeptide chain luteinizing hormone receptor into a cleaving, two subunit receptor. Eur J Biochem 268:2261-2269
20. Govaerts C, Lefort A, Costagliola S, Wodak SJ, Ballesteros JA, Van Sande J, Pardo L, Vassart G 2001 A conserved Ash in transmembrane helix 7 is an on/ off switch in the activation of the thyrotropin receptor. J Biol Chem 276:22991-22999
21. Chazenbalk GD, Rapoport B 1994 Cleavage of the thyrotropin receptor does not occur at a classical subtilisin-related proprotein covertase endoproteolytic site. J Biol Chem 269:32209-32213
22. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont J, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409:469-474
23. Kopp P, Muirhead S, Jourdain N, Gu W-X, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (Serine281-Isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639
24. Ho SC, Van Sande J, Lefort A, Vassart G, Costagliola S 2001 Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142:2760-2767
25. Nishi S, Nakabayashi K, Kobilka B, Hsueh AJ 2002 The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors. J Biol Chem 277:3958-3964
26. Knopp J, Stolc V, Tong W 1983 Trypsin increases the production of cAMP in isolated bovine thyroid cells. FEBS Lett 155:47-49
27. Friedman Y, Wilger J, Crowell D, Burke G 1983 Effects of proteolytic enzymes and protease inhibitors on bovine thyroid adenylate cyclase activity. Endocrinology 112:1674-1679
28. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Seto P, Rapoport B 1991 A new structural model for the thyrotropin (TSH) receptor as determined by covalent crosslinking of TSH to the recombinant receptor in intact cells: evidence for a single polypeptide chain. Mol Endocrinol 5:1607-1612
29. Buckland PR, Rickards CR, Howells RD, Jones ED, Rees Smith B 1982 Photo-affinity labelling of the thyrotropin receptor. FEBS Lett 145:245-249